← Open Payments lookup

YURY MALACHEVSKY: Open Payments

NPI 1326443086 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,490 in 90 payments from 19 companies in 2025. Trend: 2023 $1,823 · 2024 $1,996 · 2025 $1,490

Food & beverage: $1,490
CompanyPaymentsAmount
Amgen Inc.15$237
Novo Nordisk Inc22$233
AstraZeneca Pharmaceuticals LP5$153
Bayer Healthcare Pharmaceuticals Inc.7$150
Lilly USA, LLC14$133
ABBVIE INC.4$93
Boehringer Ingelheim Pharmaceuticals, Inc.3$76
GlaxoSmithKline, LLC.3$69
Inspire Medical Systems, Inc.2$58
Astellas Pharma US Inc2$55

Products named: Ozempic, Kerendia, KRYSTEXXA, JARDIANCE, AIRSUPRA, Rybelsus, OTEZLA, SHINGRIX.

Industry payments across MD — which companies pay providers there.